Cambridge, MA
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles associated with agonist antibody drug development.
diagonaltx.comThese are collections Diagonal Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$128,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Diagonal Therapeutics.